-
srdr.ahrq.gov/projects/1565/studies/188961
January 01, 2016 - No CPAP
Baseline N/A
N Analyzed
1341
1336 … No CPAP
Baseline N/A
N Analyzed
1341
1336 … No CPAP
Baseline N/A
N Analyzed
1335
1332 … No CPAP
Baseline N/A
N Analyzed
1332
1332 … No CPAP
Baseline N/A
N Analyzed
1346
1341
-
srdr.ahrq.gov/projects/1312/studies/133186
January 01, 2015 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … SE
2.8
3.13
8 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133344
January 01, 2011 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133234
January 01, 2015 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 8.3
9.2
SE
4 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 20
25.9
SE
4 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133274
January 01, 2012 - Time Point
Measure
Exposure 1
Exposure 2
Control 1
baseline N/A
N Analyzed … Time Point
Measure
Exposure 1
Exposure 2
Control 1
baseline N/A
N Analyzed … Time Point
Measure
Exposure 1
Exposure 2
Control 1
baseline N/A
N Analyzed … Time Point
Measure
Exposure 1
Exposure 2
Control 1
baseline N/A
N Analyzed … Time Point
Measure
Exposure 1
Exposure 2
Control 1
baseline N/A
N Analyzed
-
srdr.ahrq.gov/projects/1542/studies/186855
January 01, 2018 - Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
372 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
367 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
364 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
369 … Triptans: None (before or during pregnancy)
Not reported N/A
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188528
January 01, 2016 - No CPAP
56.9 months
N Analyzed
122
122 … No CPAP
56.9 months
N Analyzed
122
122 … No CPAP
56.9 months
N Analyzed
122
122 … No CPAP
1 years
N Analyzed
69
78 … No CPAP
Baseline N/A
N Analyzed
30
26
-
srdr.ahrq.gov/projects/1312/studies/133179
January 01, 2016 - 4.2
4.9
SE
20 weeks
N Analyzed … Population: women
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 2.8
4.7
SE
20 weeks
N Analyzed … 1.5
2
SE
20 weeks
N Analyzed … Population: women
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133188
January 01, 2009 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 months
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 months
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 months
N Analyzed … SE
2.94
2.04
1 months
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 months
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133198
January 01, 2014 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … SE
4
5
4 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … SE
2
2
4 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133216
January 01, 2015 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 8
6
SE
12 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 11
9
SE
12 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133233
January 01, 2010 - Participants
Time Point
Measure
Exposure 1
Exposure 2
Control 1
0 weeks
N Analyzed … .81
.56
SE
11 weeks
N Analyzed … .69
.49
SE
11 weeks
N Analyzed … .35
.34
SE
11 weeks
N Analyzed … 1.02
.84
SE
11 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133237
January 01, 2011 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 7.05
8.29
SE
8 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/147768
January 01, 2017 - Participants
Time Point
Measure
Exposure 1
Control 1
Exposure 2
0 weeks
N Analyzed … SE
22.8
23.8
2 weeks
N Analyzed … Participants
Time Point
Measure
Exposure 1
Control 1
Exposure 2
0 weeks
N Analyzed … SE
4
4.2
2 weeks
N Analyzed … SE
.5
.5
2 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188746
January 01, 2009 - No CPAP
62 months
N Analyzed
NR
NR … No CPAP
62 months
N Analyzed
NR
NR … No CPAP
62 months
N Analyzed
NR
NR … No CPAP
62 months
N Analyzed
NR
NR … No CPAP
62 months
N Analyzed
NR
NR
-
srdr.ahrq.gov/projects/1565/studies/188971
January 01, 2017 - No CPAP
Baseline N/A
N Analyzed
18
20 … No CPAP
Baseline N/A
N Analyzed
18
20 … No CPAP
Baseline N/A
N Analyzed
18
20 … No CPAP
Baseline N/A
N Analyzed
18
20 … ERROR
Baseline N/A
N Analyzed
18
20
-
srdr.ahrq.gov/projects/1312/studies/133114
January 01, 2008 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 days
N Analyzed … 36.1
24.73
SE
90 days
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 days
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 days
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 days
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133207
January 01, 2014 - All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 1.1
.9
SE
6 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 11
7.79
SE
6 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/189215
January 01, 2017 - Home respiratory polygraphy (HRP)
Baseline N/A
N Analyzed
212 … In-laboratory polysomnography (PSG)
Baseline N/A
N Analyzed
212 … In-laboratory polysomnography (PSG)
Baseline N/A
N Analyzed
212 … In-laboratory polysomnography (PSG)
Baseline N/A
N Analyzed
212 … In-laboratory polysomnography (PSG)
Baseline N/A
N Analyzed
212
-
srdr.ahrq.gov/projects/1520/studies/186781
January 01, 2019 - IR: No percutaneous drainage
30 days
N Analyzed
115
332
Adj. … IR: No percutaneous drainage
30 days
N Analyzed
18
197
Adj. … IR: No percutaneous drainage
30 days
N Analyzed
97
135
Adj. … IR: No percutaneous drainage
30 days
N Analyzed
18
197
Adj. … IR: No percutaneous drainage
30 days
N Analyzed
97
135
Adj.